Concepedia
Statistics
Publications
6
Citations
599
H-Index
Active since
2003
Affiliations
UCB Pharma (Belgium)(Current)
Biogen (United States)
Regeneron (United States)
Amgen (United States)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Laura I. Salazar‐Fontana is an author at UCB Pharma (Belgium) specializing in pharmacy, cell biology, and life sciences.
Publications per year
2003–2022
ERM proteins regulate cytoskeleton relaxation promoting T cell–APC conjugation
Sophie Faure, Laura I. Salazar‐Fontana, Monique Sémichon et al. · Nature Immunology · 2004 · 280 citations
Life Sciences, Cell Biology, Molecular Biology +13
The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells
Mónica Gumá, Lisa K. Busch, Laura I. Salazar‐Fontana et al. · European Journal of Immunology · 2005 · 88 citations · Full text
Life Sciences, Cell Biology, Immunology +15
CD28 Engagement Promotes Actin Polymerization Through the Activation of the Small Rho GTPase Cdc42 in Human T Cells
Laura I. Salazar‐Fontana, Valarie A. Barr, Lawrence E. Samelson et al. · The Journal of Immunology · 2003 · 87 citations · Full text
Life Sciences, Cell Biology, Immunology +17
2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)
Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text
Pharmacy, Biomedical Sciences, Pharmaceutical Analysis +16
2014 White Paper on Recent Issues in Bioanalysis: A Full Immersion in Bioanalysis (Part 3 – LBA and Immunogenicity)
Lauren Stevenson, Lakshmi Amaravadi, Heather Myler et al. · Bioanalysis · 2014 · 43 citations
Pharmacy, Biomedical Sciences, Pharmaceutical Analysis +15
1–5 of 6